Overview

Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Montelukast Tablet under fasted conditions
Phase:
Early Phase 1
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Montelukast